Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Евразийские клинические рекомендации. 2016 год

1. CLSI. Performance standard for antimicrobial susceptibility testing. Twenty-fourth Informational Supplement. CLSI document M100–S24. Wayne, PA: Clinical and Laboratory Standard Institute, 2014.
2. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. 2015. http://www.eucast.org.
3. Козлов Р.С., Сивая О.В., Кречикова О.И., Иванчик Н.В., группа исследователей проекта «ПеГАС». Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999–2009 гг. (Результаты многоцентрового проспективного исследования ПеГАС). Клин. микробиология и антимикроб. химиотерапия. 2010; 12: 1–13. / Kozlov R.S., Sivaya O.V., Krechikova O.I., Ivanchik N.V., gruppa issledovateley proekta «PeGAS». Dinamika rezistentnosti Streptococcus pneumoniae k antibiotikam v Rossii za period 1999–2009 gg. (Rezul'taty mnogotsentrovogo prospektivnogo issledovaniya PeGAS). Klin. mikrobiologiya i antimikrob. khimioterapiya. 2010; 12: 1–13. [in Russian]
4. Савинова Т.А., Сидоренко С.В., Буданов С.В., Грудинина С.А. Динамика распространения резистентности к беталактамным антибиотикам среди Streptococcus pneumoniae и ее клиническая значимость. Антибиотики и химиотерапия. 2010; 55: 12–20. / Savinova T.A., Sidorenko S.V., Budanov S.V., Grudinina S.A. Dinamika rasprostraneniya rezistentnosti k betalaktamnym antibiotikam sredi Streptococcus pneumoniae i ee klinicheskaya znachimost'. Antibiotiki i khimioterapiya. 2010; 55: 12–20. [in Russian]
5. Mayanskiy N, Alyabieva N, Ponomarenko O et al. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia. Int J Infect Dis 2014; 20: 58–62.
6. Козлов Р.С., Сухорукова М.В., Сидоренко С.В. и др. Чувствительность основных возбудителей бактериальных инфекций к цефтаролину в Российской Федерации. Клин. микробиология и антимикроб. химиотерапия. 2015; 17: 217–26. / Kozlov R.S., Sukhorukova M.V., Sidorenko S.V. i dr. Chuvstvitel'nost' osnovnykh vozbuditeley bakterial'nykh infektsiy k tseftarolinu v Rossiyskoy Federatsii. Klin. mikrobiologiya i antimikrob. khimioterapiya. 2015; 17: 217–26. [in Russian]
7. Калиногорская О.С., Беланов С.С., Волкова М.О. и др. Антибиотикорезистентность и серотиповый состав Streptococcus pneumonia, выделенных у детей в Санкт-Петербурге в 2010–2013 гг. Антибиотики и химиотерапия. 2015; 60 (1–2): 9–18. / Kalinogorskaya O.S., Belanov S.S., Volkova M.O. i dr. Antibiotikorezistentnost' i serotipovyy sostav Streptococcus pneumonia, vydelennykh u detey v Sankt-Peterburge v 2010–2013 gg. Antibiotiki i khimioterapiya. 2015; 60 (1–2): 9–18. [in Russian]
8. Jacobs MR. Building in efficacy: developing solutions to combat drug-resistant S. pneumoniae. Clin Microbiol Infect 2004; 10 (Suppl. 2): 18–27.
9. Fallon RM, Kuti JL, Doern GV et al. Pharmacodynamic Target Attainment of Oral beta-Lactams for the Empiric Treatment of Acute Otitis Media in Children. Paediatr Drugs 2008; 10: 329–35.
10. Reinert RR, Filimonova OY, Al-Lahham A et al. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia. Antimicrob Agents Chemother 2008; 52: 2260–2.
11. Сидоренко С.В., Грудинина С.А., Филимонова О.Ю. и др. Резистентность к макролидам и линкозамидам среди Streptococcus pneumoniae и Streptococcus pyogenes в Российской Федерации. Клин. фармакология и терапия. 2008; 17: 1–5. / Sidorenko S.V., Grudinina S.A., Filimonova O.Yu. i dr. Rezistentnost' k makrolidam i linkozamidam sredi Streptococcus pneumoniae i Streptococcus pyogenes v Rossiyskoy Federatsii. Klin. farmakologiya i terapiya. 2008; 17: 1–5. [in Russian]
12. Филимонова О.Ю., Грудинина С.А., Сидоренко С.В. Антибиотикорезистентность штаммов Haemophilus influenzae, выделенных в Москве с 2002 по 2004 г. Антибиотики и химиотерапия. 2004; 49: 14–21. / Filimonova O.Yu., Grudinina S.A., Sidorenko S.V. Antibiotikorezistentnost' shtammov Haemophilus influenzae, vydelennykh v Moskve s 2002 po 2004 g. Antibiotiki i khimioterapiya. 2004; 49: 14–21. [in Russian]
13. Сивая О.В., Козлов Р.С., Кречикова О.И. и др. Антибиотикорезистентность Haemophilus Influenzae в России: результаты многоцентровогопроспективного исследования ПЕГАС. Клин. микробиология и антимикроб. химиотерапия. 2014; 16: 57–69. / Sivaya O.V., Kozlov R.S., Krechikova O.I. i dr. Antibiotikorezistentnost' Haemophilus Influenzae v Rossii: rezul'taty mnogotsentrovogoprospektivnogo issledovaniya PEGAS. Klin. mikrobiologiya i antimikrob. khimioterapiya. 2014; 16: 57–69. [in Russian]
14. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007; 20: 368–89.
15. Jacobs MR. How can we predict bacterial eradication? Int J Infect Dis 2003; 7 (Suppl. 1): S13–20.
16. Волков И.К., Катосова Л.К., Щербакова Т.Ш., Клюкина Д.З. Moraxella catarrhalis при хронических и рецидивирующих инфекциях дыхательных путей у детей. Антибиотики и химиотерапия. 2004; 49: 43–7. / Volkov I.K., Katosova L.K., Shcherbakova T.Sh., Klyukina D.Z. Moraxella catarrhalis pri khronicheskikh i retsidiviruyushchikh infektsiyakh dykhatel'nykh putey u detey. Antibiotiki i khimioterapiya. 2004; 49: 43–7. [in Russian]
17. Азовскова О.В., Иванчик Н.В., Дехнич А.В. и др. Динамика антибиотикорезистентности респираторных штаммов Streptococcus pyogenes в России. Клин. микробиология и антимикроб. химиотерапия. 2012; 4: 309–21. / Azovskova O.V., Ivanchik N.V., Dekhnich A.V. i dr. Dinamika antibiotikorezistentnosti respiratornykh shtammov Streptococcus pyogenes v Rossii. Klin. mikrobiologiya i antimikrob. khimioterapiya. 2012; 4: 309–21. [in Russian]
18. Катосова Л.К., Лазарева А.В., Хохлова Т.А. и др. Распространение и механизмы устойчивости к макролидам Streptococcus pyogenes, выделенных у детей. Антибиотики и химиотерапия. 2016, в печати. / Katosova L.K., Lazareva A.V., Khokhlova T.A. i dr. Rasprostranenie i mekhanizmy ustoychivosti k makrolidam Streptococcus pyogenes, vydelennykh u detey. Antibiotiki i khimioterapiya. 2016, v pechati. [in Russian]
19. Сидоренко С.В., Иванов Д.В. Результаты изучения распространения антибиотикорезистентности среди внебольничных возбудителей инфекций мочевыводящих путей в Москве. Фаза I. Антибиотики и химиотерапия. 2005; 50: 3–10. / Sidorenko S.V., Ivanov D.V. Rezul'taty izucheniya rasprostraneniya antibiotikorezistentnosti sredi vnebol'nichnykh vozbuditeley infektsiy mochevyvodyashchikh putey v Moskve. Faza I. Antibiotiki i khimioterapiya. 2005; 50: 3–10. [in Russian]
20. Рафальский В.В., Страчунский Л.С., Кречикова О.И. и др. Резистентность возбудителей амбулаторных инфекций мочевыводящих путей по данным многоцентровых микробиологических исследований UTIAP-I И UTIAP-H. Урология. 2004; с. 13–7. / Rafal'skiy V.V., Strachunskiy L.S., Krechikova O.I. i dr. Rezistentnost' vozbuditeley ambulatornykh infektsiy mochevyvodyashchikh putey po dannym mnogotsentrovykh mikrobiologicheskikh issledovaniy UTIAP-I I UTIAP-H. Urologiya. 2004; s. 13–7. [in Russian]
21. Палагин И.С., Сухорукова М.В., Дехнич А.В. и др., исследовательская группа «ДАРМИС». Современное состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевых путей в России: результаты исследования «ДАРМИС» (2010-2011). Клин. микробиология и антимикроб. химиотерапия. 2012; 14: 280–302. / Palagin I.S., Sukhorukova M.V., Dekhnich A.V. i dr., issledovatel'skaya gruppa «DARMIS». Sovremennoe sostoyanie antibiotikorezistentnosti vozbuditeley vnebol'nichnykh infektsiy mochevykh putey v Rossii: rezul'taty issledovaniya «DARMIS» (2010-2011). Klin. mikrobiologiya i antimikrob. khimioterapiya. 2012; 14: 280–302. [in Russian]
22. Рафальский В.В., Довгань Е.В., Деревицкий А.В. Цефиксим: клиническая фармакология и место в терапии инфекций урогенитального тракта. Урология. 2011; 2: 63–6. / Rafal'skiy V.V., Dovgan' E.V., Derevitskiy A.V. Tsefiksim: klinicheskaya farmakologiya i mesto v terapii infektsiy urogenital'nogo trakta. Urologiya. 2011; 2: 63–6. [in Russian]
23. Grabe M et al. Guidelines Urological Infections. V. 2. European Association of Urology, 2015.
24. Kubanova A, Frigo N, Kubanov A et al. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia. Sex Transm Infect 2008; 84: 285–9.
25. Kubanova A, Frigo N, Kubanov A et al. The Russian gonococcal antimicrobial susceptibility programme (RU-GASP) – national resistance prevalence in 2007 and 2008, and trends during 2005–2008. Euro Surveill 2010; 15.
26. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273: 214–9.
27. Ball P, Baquero F, Cars O et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002; 49 (1): 31–40.
28. Schlemmer B. Impact of registration procedures on antibiotic polices. Clin Microbiol Infect Dis 2001; 7 (Suppl. 6): 5–8.
29. Gonzales R, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134 (6): 479–86.
30. Snow V, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001; 134 (6): 487–9.
31. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infection, and bronchitis by ambulatory care physicians. JAMA 1997; 278: 901–4.
32. Hickner JM, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134 (6): 498–505.
33. Williams JW, Aguilar C, Makela M et al. Antibiotic therapy for acute sinusitis: a systematic literature review. In: R.Douglas, C.Bridges-Webb, eds. Acute Respiratory Infections Module of the Cochrane Database of Systematic reviews. The cochrane Library. Oxford: Updated Software, 1997.
34. Zucher DR, Balk E, Engels E et al. Diagnosos and treatment of acute bacterial rhinosinusitis. Agency for Health Care Policy and Research Publication No. 99–E016. Evidence Report/Technology Assessment Number 9. www.ahrq.gov/clinic/sinusitis.htm.
35. Guo D, Cai Y, Chai D et al. The cardiotoxicity of macrolides: a systematic review. Pharmazie 2010; 65 (9): 631–40.
36. Ray WA, Murray KT, Hall K et al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012; 366 (20): 1881–90.
37. Paterson JM, Mamdani MM, Manno M et al. Fluoroquinolone therapy and idiosyncratic liver injuri: a population-based study. CMAJ 2012; 184 (14): 1565–70.
38. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis 2001; 33 (Suppl. 3): S206–13.
39. Guillemot D. How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach. Clin Microbiol Infect 2001; 7 (Suppl. 5): 19–23.
40. Kristinsson KG et al. Microb Drug Resist 1997; 3: 117–23.
41. Baquero F. Microb Drug Resist 1995; 1: 115–20.
42. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075–8.
43. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6.
44. Белоусов Ю.Б. Перспективы для клинического фармаколога. Качественная клин. практика. 2002; 2: 3–5. / Belousov Yu.B. Perspektivy dlya klinicheskogo farmakologa. Kachestvennaya klin. praktika. 2002; 2: 3–5. [in Russian]
45. Дворецкий Л.И., Яковлев С.В. Ошибки антибактериальной терапии инфекций дыхательных путей в амбулаторной практике. Антибиотики и химиотерапия. 2005; 50: 5–6. / Dvoretskiy L.I., Yakovlev S.V. Oshibki antibakterial'noy terapii infektsiy dykhatel'nykh putey v ambulatornoy praktike. Antibiotiki i khimioterapiya. 2005; 50: 5–6. [in Russian]
46. Елисеева Е.В., Гайнуллина Ю.И., Гельцер Б.И. Эффективность службы клинической фармакологии в оптимизации использования антибактериальных лекарственных средств. Зам. глав. врача. 2010; 7: 70–6. / Eliseeva E.V., Gaynullina Yu.I., Gel'tser B.I. Effektivnost' sluzhby klinicheskoy farmakologii v optimizatsii ispol'zovaniya antibakterial'nykh lekarstvennykh sredstv. Zam. glav. vracha. 2010; 7: 70–6. [in Russian]
47. Елисеева Е.В., Солодовников В.В., Гайнуллина Ю.И., Преображенская О.В. Значение службы клинической фармакологии в оптимизации использования финансовых средств по программе дополнительного лекарственного обеспечения. Пробл. стандартизации в здравоохранении. 2008; 3: 9–12. / Eliseeva E.V., Solodovnikov V.V., Gaynullina Yu.I., Preobrazhenskaya O.V. Znachenie sluzhby klinicheskoy farmakologii v optimizatsii ispol'zovaniya finansovykh sredstv po programme dopolnitel'nogo lekarstvennogo obespecheniya. Probl. standartizatsii v zdravookhranenii. 2008; 3: 9–12. [in Russian]
48. Елисеева Е.В., Шмыкова И.И., Седых А.В. и др. Последипломный этап подготовки врачей на кафедре клинической фармакологии ВГМУ: организационно-методические и клинические аспекты. Тихоокеанский мед. журн. 2007; с. 70–2. / Eliseeva E.V., Shmykova I.I., Sedykh A.V. i dr. Poslediplomnyy etap podgotovki vrachey na kafedre klinicheskoy farmakologii VGMU: organizatsionno-metodicheskie i klinicheskie aspekty. Tikhookeanskiy med. zhurn. 2007; s. 70–2. [in Russian]
49. О совершенствовании стратегии и тактики использования антибиотиков в профилактике внутрибольничных инфекций. Письмо ДЗАПК №36.1833 от 15.08.2002. / O sovershenstvovanii strategii i taktiki ispol'zovaniya antibiotikov v profilaktike vnutribol'nichnykh infektsiy. Pis'mo DZAPK №36.1833 ot 15.08.2002. [in Russian]
50. Яковлева Т.В. О совершенствовании законодательтва в сфере обращения лекарственных средств. Главврач. 2007; 6: 50–3. / Yakovleva T.V. O sovershenstvovanii zakonodatel'tva v sfere obrashcheniya lekarstvennykh sredstv. Glavvrach. 2007; 6: 50–3. [in Russian]
51. Centre for Clinical Practice at NICE (UK). Respiratory Tract Infections – Antibiotic Prescribing: Prescribing of Antibiotics for Self-Limiting Respiratory Tract Infections in Adults and Children in Primary Care. NICE Clinical Guidelines, No. 69. London: National Institute for Health and Clinical Excellence (UK), 2008.
52. Ross H.A. Diagnosis and Treatment of Acute Bronchitis. Am Fam Physician 2010; 82 (11): 1345–50.
53. Common cold. UpToDateR www.uptodate.com
54. Ghany MG, Nelson DR, Strader DB et al. American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54 (4): 1433–44.
55. Trasande L, Blustein J, Liu M et al. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 2013; 37: 16–23.
56. Million M, Lagier JC, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect 2013; 19: 305–13.
57. Moore PR, Evenson A et al. Use of sulfasuxidine, streptothricin, and streptomycin in nutritional studies with the chick. J Biol Chem 1946; 165: 437–41.
58. Баранов А.А., Таточенко В.К., Бакрадзе М.Д. Лихорадящий ребенок. Протоколы диагностики и лечения. 2-е изд. М.: Педиатръ, 2015. / Baranov A.A., Tatochenko V.K., Bakradze M.D. Likhoradyashchiy rebenok. Protokoly diagnostiki i lecheniya. 2-e izd. M.: Pediatr", 2015. [in Russian]
59. Spurling GKP, Del Mar CB, Dooley L, Foxlee RRF. Delayed antibiotics for respiratory infections. Cochrane Database Sys Rev 2013; 4: CD004417.
60. Козлов Р.С., Кречикова О.И., Миронов К.О. и др. Результаты исследования распространенности в России внебольничной пневмонии и острого среднего отита у детей в возрасте до 5 лет (PAPIRUS). Роль S. pneumoniae и H. influenzae в этиологии данных заболеваний. Клин. микробиология и антимикроб. химиотерапия. 2013; 15 (4): 1–12. / Kozlov R.S., Krechikova O.I., Mironov K.O. i dr. Rezul'taty issledovaniya rasprostranennosti v Rossii vnebol'nichnoy pnevmonii i ostrogo srednego otita u detey v vozraste do 5 let (PAPIRUS). Rol' S. pneumoniae i H. influenzae v etiologii dannykh zabolevaniy. Klin. mikrobiologiya i antimikrob. khimioterapiya. 2013; 15 (4): 1–12. [in Russian]
61. Hoberman A, Paradise JL, Rockette HE et al. Treatment of Acute Otitis Media in Children under 2 Years of Age. N Engl J Med 2011; 364: 105–15.
62. Tähtinen PA, Laine MK, Huovinen P et al. A Placebo-Controlled Trial of Antimicrobial Treatment for Acute Otitis Media. N Engl J Med 2011; 364: 116–26.
63. Venekamp RP, Sanders S, Glasziou PP et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2013; 1: CD000219.
64. McCormick DP, Chonmaitree T, Pittman C et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics 2005; 115: 1455–65.
65. Spiro DM, Tay KY, Arnold DH et al. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA 2006; 296: 1235–41.
66. Little P, Gould C, Williamson I et al. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001; 322: 336–42.
67. Lieberthal AS, Carroll AE, Chonmaitree T et al. The Diagnosis and Management of Acute Otitis Media. Pediatrics 2013; 131: e964–e999.
68. Dagan R, Hoberman A, Johnson C et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 829–37.
69. Hoberman A, Dagan R, Leibovitz E et al. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J 2005; 24: 525–32.
70. Маянский Н.А., Алябьева Н.М., Иваненко А.М. и др. Бактериальная этиология острого среднего отита у детей до 5 лет: роль Streptococcus pneumoniae. Вопр. диагностики в педиатрии. 2013; 5 (3): 5–13. / Mayanskiy N.A., Alyab'eva N.M., Ivanenko A.M. i dr. Bakterial'naya etiologiya ostrogo srednego otita u detey do 5 let: rol' Streptococcus pneumoniae. Vopr. diagnostiki v pediatrii. 2013; 5 (3): 5–13. [in Russian]
71. Esposito S, Principi N. Italian Society of pediatrics et al. Guidelines for diagnosis and treatment of acute and subacute rhinosinusitis in children pneumonia. J Chemother 2008; 20 (2): 147–57.
72. Гаращенко Т.И., Богомильский М.Р., Радциг Е.Ю. и др. Профилактика и лечение инфекций верхних дыхательных путей у детей. Лечащий врач. 2001; 10. / Garashchenko T.I., Bogomil'skiy M.R., Radtsig E.Yu. i dr. Profilaktika i lechenie infektsiy verkhnikh dykhatel'nykh putey u detey. Lechashchiy vrach. 2001; 10. [in Russian]
73. Chow AW, Benninger MS, Brook I et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clin Infect Dis 2012; 54: e72–e112.
74. Fokkens WJ, Lund VJ, Mullol J et al. European Position Paper on Nasal Polyps 2012. Rhinology 2012; 50 (Suppl. 23): 1–298.
75. Anon JB. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management. Paediatr Drugs 2003; 5 (Suppl. 1): 25–33.
76. Payne SC, Benninger MS. Staphylococcus. Aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis. Clin Infect Dis 2007; 45 (10): e121–127.
77. Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children: a double-blind, placebo-controlled trial. Pediatrics 1986; 77: 795–800.
78. Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics 2009; 124: 9–15.
79. Garbutt JM, Goldstein M, Gellman E et al. A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics 2001; 107: 619–25.
80. Этиопатогенетическая терапия заболеваний верхних дыхательных путей и уха: методические рекомендации. Под ред. С.В.Рязанцева. СПб.: Полифорум Групп, 2015. / Etiopatogeneticheskaya terapiya zabolevaniy verkhnikh dykhatel'nykh putey i ukha: metodicheskie rekomendatsii. Pod red. S.V.Ryazantseva. SPb.: Poliforum Grupp, 2015. [in Russian]
81. Черкасова Е.Н., Кузнецова Т.А. Острый тонзиллит на педиатрическом участке: этиологическая диагностика и лечение. Педиатрическая фармакология. 2015; 12 (2): 197–200. DOI: 10.15690/pf.v12i2.1283 / Cherkasova E.N., Kuznetsova T.A. Ostryy tonzillit na pediatricheskom uchastke: etiologicheskaya diagnostika i lechenie. Pediatricheskaya farmakologiya. 2015; 12 (2): 197–200. DOI: 10.15690/pf.v12i2.1283 [in Russian]
82. Катосова Л.К., Намазова Л.С., Кузнецова М.Н. и др. Мониторинг носительства условно патогенной микрофлоры ротоглотки здоровых детей. Педиатрическая фармакология. 2007; 4 (2): 23–9. / Katosova L.K., Namazova L.S., Kuznetsova M.N. i dr. Monitoring nositel'stva uslovno patogennoy mikroflory rotoglotki zdorovykh detey. Pediatricheskaya farmakologiya. 2007; 4 (2): 23–9. [in Russian]
83. Русанова Е.В., Феклисова Л.В., Медведева Е.А., Елезова Л.И. Состояние микробиоты слизистых оболочек ротоглотки детей при поступлении в санаторий. Сборник аннотированных докладов VI Всероссийской научно-практической конференции «Инфекционные аспекты соматической патологии у детей», Москва, 20–21 мая 2013; с. 93–5.  / Rusanova E.V., Feklisova L.V., Medvedeva E.A., Elezova L.I. Sostoianie mikrobioty slizistykh obolochek rotoglotki detei pri postuplenii v sanatorii. Sbornik annotirovannykh dokladov VI Vserossiiskoi nauchno-prakticheskoi konferentsii «Infektsionnye aspekty somaticheskoi patologii u detei», Moskva, 20–21 maia 2013; s. 93–5.  [in Russian]
84. Белов Б.С., Гришаева Т.П. А-Стрептококковый тонзиллит: современные аспекты антибактериальной терапии. Педиатрическая фармакология. 2007; 4 (3): 58–66. / Belov B.S., Grishaeva T.P. A-Streptokokkovyy tonzillit: sovremennye aspekty antibakterial'noy terapii. Pediatricheskaya farmakologiya. 2007; 4 (3): 58–66. [in Russian]
85. Cooper RJ, Hoffman JR, Bartlett JG et al, American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine; Centers for Disease Control. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001; 134: 509–17.
86. Little P, Gould C, Williamson I et al. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 1997; 315: 350–2.
87. Zwart S, Rovers MM, de Melker RA, Hoes AW. Penicillin for acute sore throat in children: randomised, double blind trial. BMJ 2003; 327: 1324.
88. Giraldez-Garcia C, Rubio B, Gallegos-Braun JF et al. Diagnosis and management of acute pharyngitis in a paediatric population: a cost-effectiveness analysis. Eur J Pediatr 2011; 170 (8): 1059–67.
89. Дарманян А.С., Бакрадзе М.Д. Проблема острого тонзиллита в детском возрасте. Мед. совет. Педиатрия. 2013; 3 (1): 69–72. / Darmanyan A.S., Bakradze M.D. Problema ostrogo tonzillita v detskom vozraste. Med. sovet. Pediatriya. 2013; 3 (1): 69–72. [in Russian]
90. Domingues О, Rojo P, De las Heras S et al. Clinical presentation and characteristics of pharyngeal adenovirus infections. Pediatric Infect Dis J 2005; 24 (8): 733–44.
91. Cohen R, Levy C, Ovetchkine P et al. Evaluation of streptococcal clinical scores, rapid antigen detection tests and cultures for childhood pharyngitis. Eur J Pediatr 2004; 163: 281–2.
92. Lieu TA, Fleisher GR, Schwartz JS. Cost-effectiveness of rapid latex agglutination testing and throat culture for streptococcal pharyngitis. Pediatrics 1990; 85: 246–56.
93. Group ESTG, Pelucchi C, Grigoryan L et al. Guideline for the management of acute sore throat. Clin Microbiol Infect 2012; 18 (Suppl. 1): 1–28.
94. Chiappini E, Regoli M, Bonsignori F et al. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther 2011; 33: 48–58.
95. Катосова Л.К., Пономаренко О.А., Хохлова Т.А. и др. Возрастающая резистентность к макролидам Streptococcus pyogenes и молекулярные механизмы ее определяющие. Конференция МАКМАХ. М., 2015. / Katosova L.K., Ponomarenko O.A., Khokhlova T.A. i dr. Vozrastaiushchaia rezistentnost' k makrolidam Streptococcus pyogenes i molekuliarnye mekhanizmy ee opredeliaiushchie. Konferentsiia MAKMAKh. M., 2015. [in Russian]
96. Blasi F. Atypical pathogens and respiratory tract infections. Eur Respir J 2004; 24: 171–81.
97. Савенкова М.С. Хламидийная и микоплазменная инфекции в практике педиатра. Consilium Medicum. Педиатрия (Прил.). 2005; 1: 10–7. / Savenkova M.S. Khlamidiynaya i mikoplazmennaya infektsii v praktike pediatra. Consilium Medicum. Pediatrics (Suppl.). 2005; 1: 10–7. [in Russian]
98. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Sys Rev 2014: CD000245. DOI: 10.1002/14651858.CD000245.pub2
99. Ieven M. Diagnosis of Mycoplasma pneumoniae infections. Educational Workshop 07: Mycoplasma pneumoniae: epidemiology, diagnosis and treatment. 25th ECCMID, Copenhagen, Denmark, 25 April 2015 https: //www.escmid.org/ESGMI/
100. Спичак Т.В., Катосова Л.К., Яцышина С.Б. и др. Критический взгляд на результаты лабораторной диагностики внебольничной пневмонии микоплазменной этиологии у детей. Педиатрия. 2014; 87 (3): 46–55. / Spichak T.V., Katosova L.K., Iatsyshina S.B. i dr. Kriticheskii vzgliad na rezul'taty laboratornoi diagnostiki vnebol'nichnoi pnevmonii mikoplazmennoi etiologii u detei. Pediatriia. 2014; 87 (3): 46–55. [in Russian]
101. Nilsson AC, Björkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiology 2008; 8: 93. DOI: 10.1186/1471-2180-8-93
102. Spuesens EBM, Fraaij PLA, Visser EG et al. Carriage of Mycoplasma pneumoniae in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study. PLOS Med 2013; 10 (5): e1001444. DOI: 10.1371/journal.pmed.1001444
103. Kimpen JLL, Hammer J. Bronchiolitis in infants and children. Eur Respir Society Mon 2006; 37: 360.
104. Геппе Н.А., Розинова Н.Н., Волков И.К., Мизерницкий Ю.Л. Новая рабочая классификация бронхолегочных заболеваний у детей. Доктор.ру. Педиатрия. 2009; 1: 7–18. / Geppe N.A., Rozinova N.N., Volkov I.K., Mizernitskii Iu.L. Novaia rabochaia klassifikatsiia bronkholegochnykh zabolevanii u detei. Doktor.ru. Pediatriia. 2009; 1: 7–18. [in Russian]
105. Harris M., Clarc J., Coote N et al. British Thoracic Society guidelines for the management of Сommunity-acquired pneumonia in children: update 2011. Thorax 2011; 66 (6): 548–69.
106. Bradley JS, Byington CL, Shah SS et al. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53: e25–e76. http://cid.oxfordjournals.org/content/current
107. Таточенко В.К. Педиатру на каждый день – 2012. Справочник по диагностике и лечению. Изд. 7-е, доп. М.: Боргес, 2012; с. 72, 144–6. / Tatochenko V.K. Pediatru na kazhdyi den' – 2012. Spravochnik po diagnostike i lecheniiu. Izd. 7-e, dop. M.: Borges, 2012; s. 72, 144–6. [in Russian]
108. Rudan I, Boschi-Pinto C, Biloglav Z et al. Epidemiology and etiology of childhood pneumonia. Bull WHO 2008; 86 (5): 408–16.
109. Hull J. Community-acquired pneumonia in children. Postgraduate Cours 15. Common respiratory infection in childhood: current guidelines and controversies. ERS Annual Cjngress Vienna 1–5 September 2012; p. 5–18.
110. Everard ML, Graven V, Fenton P. Community-acquired pneumonia. ERS handbook Paediatric Respiratory Medicie. 1st Ed. Eds. E.Eber, F.Medulla. Published by the European Respiratory Society, 2013; p. 233–41.
111. Esposito S, Patria MF, Tagliabue C et al. CAP in children. In: Community-acquired pneumonia. European respiratory monograph. V. 63. Eds: J.Chalmers, M.Pletz, S.Aliberti. 2014; p. 130–9.
112. Ким С.С., Спичак Т.В., Яцышина С.Б. и др. Роль вирусов при внебольничных пневмониях у детей. Вопр. диагностики в педиатрии. 2012; 4 (4): 21–5. / Kim S.S., Spichak T.V., Iatsyshina S.B. i dr. Rol' virusov pri vnebol'nichnykh pnevmoniiakh u detei. Vopr. diagnostiki v pediatrii. 2012; 4 (4): 21–5. [in Russian]
113. Ieven M, Loens K. Should Serology be Abolished in Favor of PCR for the Diagnosis of Mycoplasma pneumoniae Infections? Cur Ped Rev 2013; 9: 4915–23.
114. Esposito S, Tagliabue C, Picciolli I et al. Procalcitonin measurement for guiding antibiotic treatment in pediatric pneumonia. Respir Med 2011; 105: 1939–45.
115. Baer G, Engelcke G, Abele-Horn M et al. Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents. Eur J Clin Microbiol Infect Dis 2003; 22 (12): 742–5.
116. Ким С.С. Эффективные методы диагностики и лечения среднетяжелых внебольничных пневмоний у детей. Автореф. дис. … канд. мед. наук. М., 2012. / Kim S.S. Effektivnye metody diagnostiki i lecheniia srednetiazhelykh vnebol'nichnykh pnevmonii u detei. Avtoref. dis. … kand. med. nauk. M., 2012. [in Russian]
117. Геппе Н.А., Розинова Н.Н., Волков И.К. и др. Внебольничная пневмония у детей. Клинические рекомендации. М.: Оригинал-макет, 2015. / Geppe N.A., Rozinova N.N., Volkov I.K. i dr. Vnebol'nichnaia pnevmoniia u detei. Klinicheskie rekomendatsii. M.: Original-maket, 2015. [in Russian]
118. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008; 16 (2): CD005976.
119. Воробьев П.А. Качество медицинской помощи: проблемы оценки, контроля и управления. Пробл. стандартизации в здравоохранении. 2007; 10: 6–14. / Vorob'ev P.A. Kachestvo meditsinskoi pomoshchi: problemy otsenki, kontrolia i upravleniia. Probl. standartizatsii v zdravookhranenii. 2007; 10: 6–14. [in Russian]
120. Вялков А.И., Полесский В.А., Мартынчик С.А. Ключевые стратегии ВОЗ по совершенствованию национальных систем здравоохранения. Главврач. 2008; 5: 10–25. / Vialkov A.I., Polesskii V.A., Martynchik S.A. Kliuchevye strategii VOZ po sovershenstvovaniiu natsional'nykh sistem zdravookhraneniia. Glavvrach. 2008; 5: 10–25. [in Russian]
121. Дьяченко В.Г. Качество в современной медицине. Хабаровск: ДВГМУ, 2007. / D'iachenko V.G. Kachestvo v sovremennoi meditsine. Khabarovsk: DVGMU, 2007. [in Russian]
122. Елисеева Е.В., Гайнуллина Ю.И., Гельцер Б.И. Управление качеством в сфере применения антибактериальных препаратов. Владивосток: Дальнаука, 2010. / Eliseeva E.V., Gainullina Iu.I., Gel'tser B.I. Upravlenie kachestvom v sfere primeneniia antibakterial'nykh preparatov. Vladivostok: Dal'nauka, 2010. [in Russian]
123. Иванова И.В., Стародубов В.И. Некоторые показатели формирования кадрового потенциала медицинской и фармацевтической науки. Вестн. новых мед. технологий. 2005; 12 (2): 105–7. / Ivanova I.V., Starodubov V.I. Nekotorye pokazateli formirovaniia kadrovogo potentsiala meditsinskoi i farmatsevticheskoi nauki. Vestn. novykh med. tekhnologii. 2005; 12 (2): 105–7. [in Russian]
124. Мамедов Д.А. Организация управления информационным ресурсом в муниципальном учреждении здравоохранения. Главврач. 2008; 5: 75–85. / Mamedov D.A. Organizatsiia upravleniia informatsionnym resursom v munitsipal'nom uchrezhdenii zdravookhraneniia. Glavvrach. 2008; 5: 75–85. [in Russian]
125. Пирогов М.В. Разработка медико-экономических стандартов (опыт Московской области). Главврач. 2009; 7: 41–54. / Pirogov M.V. Razrabotka mediko-ekonomicheskikh standartov (opyt Moskovskoi oblasti). Glavvrach. 2009; 7: 41–54. [in Russian]
126. Письмо Минздравсоцразвития Российской Федерации №1242-ВС от 16.03.06. Справочно-правовая система «КонсультантПлюс». / Pis'mo Minzdravsotsrazvitiia Rossiiskoi Federatsii №1242-VS ot 16.03.06. Spravochno-pravovaia sistema «Konsul'tantPlius». [in Russian]
127. Солодовников В.В., Гайнуллина Ю.И., Елисеева Е.В., Кривелевич В.Я. Современное состояние проблемы и значение службы клинической фармакологии в оптимизации использования антибактериальных лекарственных средств. Пробл. стандартизации в здравоохранении. 2008; 9: 3–7. / Solodovnikov V.V., Gainullina Iu.I., Eliseeva E.V., Krivelevich V.Ia. Sovremennoe sostoianie problemy i znachenie sluzhby klinicheskoi farmakologii v optimizatsii ispol'zovaniia antibakterial'nykh lekarstvennykh sredstv. Probl. standartizatsii v zdravookhranenii. 2008; 9: 3–7. [in Russian]
128. How to investigate drug use in health facilities: selected drug use indicators. Geneva: World Health Organization, 2003.
129. Madaras-Kelly K. Optimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistance. Insights from the society of infectious diseases pharmacists. Pharmacotherapy 2003; 23 (12): 1627–33.

________________________________________________

1. CLSI. Performance standard for antimicrobial susceptibility testing. Twenty-fourth Informational Supplement. CLSI document M100–S24. Wayne, PA: Clinical and Laboratory Standard Institute, 2014.
2. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. 2015. http://www.eucast.org.
3. Kozlov R.S., Sivaya O.V., Krechikova O.I., Ivanchik N.V., gruppa issledovateley proekta «PeGAS». Dinamika rezistentnosti Streptococcus pneumoniae k antibiotikam v Rossii za period 1999–2009 gg. (Rezul'taty mnogotsentrovogo prospektivnogo issledovaniya PeGAS). Klin. mikrobiologiya i antimikrob. khimioterapiya. 2010; 12: 1–13. [in Russian]
4. Savinova T.A., Sidorenko S.V., Budanov S.V., Grudinina S.A. Dinamika rasprostraneniya rezistentnosti k betalaktamnym antibiotikam sredi Streptococcus pneumoniae i ee klinicheskaya znachimost'. Antibiotiki i khimioterapiya. 2010; 55: 12–20. [in Russian]
5. Mayanskiy N, Alyabieva N, Ponomarenko O et al. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia. Int J Infect Dis 2014; 20: 58–62.
6. Kozlov R.S., Sukhorukova M.V., Sidorenko S.V. i dr. Chuvstvitel'nost' osnovnykh vozbuditeley bakterial'nykh infektsiy k tseftarolinu v Rossiyskoy Federatsii. Klin. mikrobiologiya i antimikrob. khimioterapiya. 2015; 17: 217–26. [in Russian]
7. Kalinogorskaya O.S., Belanov S.S., Volkova M.O. i dr. Antibiotikorezistentnost' i serotipovyy sostav Streptococcus pneumonia, vydelennykh u detey v Sankt-Peterburge v 2010–2013 gg. Antibiotiki i khimioterapiya. 2015; 60 (1–2): 9–18. [in Russian]
8. Jacobs MR. Building in efficacy: developing solutions to combat drug-resistant S. pneumoniae. Clin Microbiol Infect 2004; 10 (Suppl. 2): 18–27.
9. Fallon RM, Kuti JL, Doern GV et al. Pharmacodynamic Target Attainment of Oral beta-Lactams for the Empiric Treatment of Acute Otitis Media in Children. Paediatr Drugs 2008; 10: 329–35.
10. Reinert RR, Filimonova OY, Al-Lahham A et al. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia. Antimicrob Agents Chemother 2008; 52: 2260–2.
11. Sidorenko S.V., Grudinina S.A., Filimonova O.Yu. i dr. Rezistentnost' k makrolidam i linkozamidam sredi Streptococcus pneumoniae i Streptococcus pyogenes v Rossiyskoy Federatsii. Klin. farmakologiya i terapiya. 2008; 17: 1–5. [in Russian]
12. Filimonova O.Yu., Grudinina S.A., Sidorenko S.V. Antibiotikorezistentnost' shtammov Haemophilus influenzae, vydelennykh v Moskve s 2002 po 2004 g. Antibiotiki i khimioterapiya. 2004; 49: 14–21. [in Russian]
13. Sivaya O.V., Kozlov R.S., Krechikova O.I. i dr. Antibiotikorezistentnost' Haemophilus Influenzae v Rossii: rezul'taty mnogotsentrovogoprospektivnogo issledovaniya PEGAS. Klin. mikrobiologiya i antimikrob. khimioterapiya. 2014; 16: 57–69. [in Russian]
14. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007; 20: 368–89.
15. Jacobs MR. How can we predict bacterial eradication? Int J Infect Dis 2003; 7 (Suppl. 1): S13–20.
16. Volkov I.K., Katosova L.K., Shcherbakova T.Sh., Klyukina D.Z. Moraxella catarrhalis pri khronicheskikh i retsidiviruyushchikh infektsiyakh dykhatel'nykh putey u detey. Antibiotiki i khimioterapiya. 2004; 49: 43–7. [in Russian]
17. Azovskova O.V., Ivanchik N.V., Dekhnich A.V. i dr. Dinamika antibiotikorezistentnosti respiratornykh shtammov Streptococcus pyogenes v Rossii. Klin. mikrobiologiya i antimikrob. khimioterapiya. 2012; 4: 309–21. [in Russian]
18. Katosova L.K., Lazareva A.V., Khokhlova T.A. i dr. Rasprostranenie i mekhanizmy ustoychivosti k makrolidam Streptococcus pyogenes, vydelennykh u detey. Antibiotiki i khimioterapiya. 2016, v pechati. [in Russian]
19. Sidorenko S.V., Ivanov D.V. Rezul'taty izucheniya rasprostraneniya antibiotikorezistentnosti sredi vnebol'nichnykh vozbuditeley infektsiy mochevyvodyashchikh putey v Moskve. Faza I. Antibiotiki i khimioterapiya. 2005; 50: 3–10. [in Russian]
20. Rafal'skiy V.V., Strachunskiy L.S., Krechikova O.I. i dr. Rezistentnost' vozbuditeley ambulatornykh infektsiy mochevyvodyashchikh putey po dannym mnogotsentrovykh mikrobiologicheskikh issledovaniy UTIAP-I I UTIAP-H. Urologiya. 2004; s. 13–7. [in Russian]
21. Palagin I.S., Sukhorukova M.V., Dekhnich A.V. i dr., issledovatel'skaya gruppa «DARMIS». Sovremennoe sostoyanie antibiotikorezistentnosti vozbuditeley vnebol'nichnykh infektsiy mochevykh putey v Rossii: rezul'taty issledovaniya «DARMIS» (2010-2011). Klin. mikrobiologiya i antimikrob. khimioterapiya. 2012; 14: 280–302. [in Russian]
22. Rafal'skiy V.V., Dovgan' E.V., Derevitskiy A.V. Tsefiksim: klinicheskaya farmakologiya i mesto v terapii infektsiy urogenital'nogo trakta. Urologiya. 2011; 2: 63–6. [in Russian]
23. Grabe M et al. Guidelines Urological Infections. V. 2. European Association of Urology, 2015.
24. Kubanova A, Frigo N, Kubanov A et al. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia. Sex Transm Infect 2008; 84: 285–9.
25. Kubanova A, Frigo N, Kubanov A et al. The Russian gonococcal antimicrobial susceptibility programme (RU-GASP) – national resistance prevalence in 2007 and 2008, and trends during 2005–2008. Euro Surveill 2010; 15.
26. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273: 214–9.
27. Ball P, Baquero F, Cars O et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002; 49 (1): 31–40.
28. Schlemmer B. Impact of registration procedures on antibiotic polices. Clin Microbiol Infect Dis 2001; 7 (Suppl. 6): 5–8.
29. Gonzales R, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134 (6): 479–86.
30. Snow V, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001; 134 (6): 487–9.
31. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infection, and bronchitis by ambulatory care physicians. JAMA 1997; 278: 901–4.
32. Hickner JM, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134 (6): 498–505.
33. Williams JW, Aguilar C, Makela M et al. Antibiotic therapy for acute sinusitis: a systematic literature review. In: R.Douglas, C.Bridges-Webb, eds. Acute Respiratory Infections Module of the Cochrane Database of Systematic reviews. The cochrane Library. Oxford: Updated Software, 1997.
34. Zucher DR, Balk E, Engels E et al. Diagnosos and treatment of acute bacterial rhinosinusitis. Agency for Health Care Policy and Research Publication No. 99–E016. Evidence Report/Technology Assessment Number 9. www.ahrq.gov/clinic/sinusitis.htm.
35. Guo D, Cai Y, Chai D et al. The cardiotoxicity of macrolides: a systematic review. Pharmazie 2010; 65 (9): 631–40.
36. Ray WA, Murray KT, Hall K et al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012; 366 (20): 1881–90.
37. Paterson JM, Mamdani MM, Manno M et al. Fluoroquinolone therapy and idiosyncratic liver injuri: a population-based study. CMAJ 2012; 184 (14): 1565–70.
38. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis 2001; 33 (Suppl. 3): S206–13.
39. Guillemot D. How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach. Clin Microbiol Infect 2001; 7 (Suppl. 5): 19–23.
40. Kristinsson KG et al. Microb Drug Resist 1997; 3: 117–23.
41. Baquero F. Microb Drug Resist 1995; 1: 115–20.
42. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075–8.
43. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6.
44. Belousov Yu.B. Perspektivy dlya klinicheskogo farmakologa. Kachestvennaya klin. praktika. 2002; 2: 3–5. [in Russian]
45. Dvoretskiy L.I., Yakovlev S.V. Oshibki antibakterial'noy terapii infektsiy dykhatel'nykh putey v ambulatornoy praktike. Antibiotiki i khimioterapiya. 2005; 50: 5–6. [in Russian]
46. Eliseeva E.V., Gaynullina Yu.I., Gel'tser B.I. Effektivnost' sluzhby klinicheskoy farmakologii v optimizatsii ispol'zovaniya antibakterial'nykh lekarstvennykh sredstv. Zam. glav. vracha. 2010; 7: 70–6. [in Russian]
47. Eliseeva E.V., Solodovnikov V.V., Gaynullina Yu.I., Preobrazhenskaya O.V. Znachenie sluzhby klinicheskoy farmakologii v optimizatsii ispol'zovaniya finansovykh sredstv po programme dopolnitel'nogo lekarstvennogo obespecheniya. Probl. standartizatsii v zdravookhranenii. 2008; 3: 9–12. [in Russian]
48. Eliseeva E.V., Shmykova I.I., Sedykh A.V. i dr. Poslediplomnyy etap podgotovki vrachey na kafedre klinicheskoy farmakologii VGMU: organizatsionno-metodicheskie i klinicheskie aspekty. Tikhookeanskiy med. zhurn. 2007; s. 70–2. [in Russian]
49. O sovershenstvovanii strategii i taktiki ispol'zovaniya antibiotikov v profilaktike vnutribol'nichnykh infektsiy. Pis'mo DZAPK №36.1833 ot 15.08.2002. [in Russian]
50. Yakovleva T.V. O sovershenstvovanii zakonodatel'tva v sfere obrashcheniya lekarstvennykh sredstv. Glavvrach. 2007; 6: 50–3. [in Russian]
51. Centre for Clinical Practice at NICE (UK). Respiratory Tract Infections – Antibiotic Prescribing: Prescribing of Antibiotics for Self-Limiting Respiratory Tract Infections in Adults and Children in Primary Care. NICE Clinical Guidelines, No. 69. London: National Institute for Health and Clinical Excellence (UK), 2008.
52. Ross H.A. Diagnosis and Treatment of Acute Bronchitis. Am Fam Physician 2010; 82 (11): 1345–50.
53. Common cold. UpToDateR www.uptodate.com
54. Ghany MG, Nelson DR, Strader DB et al. American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54 (4): 1433–44.
55. Trasande L, Blustein J, Liu M et al. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 2013; 37: 16–23.
56. Million M, Lagier JC, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect 2013; 19: 305–13.
57. Moore PR, Evenson A et al. Use of sulfasuxidine, streptothricin, and streptomycin in nutritional studies with the chick. J Biol Chem 1946; 165: 437–41.
58. Baranov A.A., Tatochenko V.K., Bakradze M.D. Likhoradyashchiy rebenok. Protokoly diagnostiki i lecheniya. 2-e izd. M.: Pediatr", 2015. [in Russian]
59. Spurling GKP, Del Mar CB, Dooley L, Foxlee RRF. Delayed antibiotics for respiratory infections. Cochrane Database Sys Rev 2013; 4: CD004417.
60. Kozlov R.S., Krechikova O.I., Mironov K.O. i dr. Rezul'taty issledovaniya rasprostranennosti v Rossii vnebol'nichnoy pnevmonii i ostrogo srednego otita u detey v vozraste do 5 let (PAPIRUS). Rol' S. pneumoniae i H. influenzae v etiologii dannykh zabolevaniy. Klin. mikrobiologiya i antimikrob. khimioterapiya. 2013; 15 (4): 1–12. [in Russian]
61. Hoberman A, Paradise JL, Rockette HE et al. Treatment of Acute Otitis Media in Children under 2 Years of Age. N Engl J Med 2011; 364: 105–15.
62. Tähtinen PA, Laine MK, Huovinen P et al. A Placebo-Controlled Trial of Antimicrobial Treatment for Acute Otitis Media. N Engl J Med 2011; 364: 116–26.
63. Venekamp RP, Sanders S, Glasziou PP et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2013; 1: CD000219.
64. McCormick DP, Chonmaitree T, Pittman C et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics 2005; 115: 1455–65.
65. Spiro DM, Tay KY, Arnold DH et al. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA 2006; 296: 1235–41.
66. Little P, Gould C, Williamson I et al. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001; 322: 336–42.
67. Lieberthal AS, Carroll AE, Chonmaitree T et al. The Diagnosis and Management of Acute Otitis Media. Pediatrics 2013; 131: e964–e999.
68. Dagan R, Hoberman A, Johnson C et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 829–37.
69. Hoberman A, Dagan R, Leibovitz E et al. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J 2005; 24: 525–32.
70. Mayanskiy N.A., Alyab'eva N.M., Ivanenko A.M. i dr. Bakterial'naya etiologiya ostrogo srednego otita u detey do 5 let: rol' Streptococcus pneumoniae. Vopr. diagnostiki v pediatrii. 2013; 5 (3): 5–13. [in Russian]
71. Esposito S, Principi N. Italian Society of pediatrics et al. Guidelines for diagnosis and treatment of acute and subacute rhinosinusitis in children pneumonia. J Chemother 2008; 20 (2): 147–57.
72. Garashchenko T.I., Bogomil'skiy M.R., Radtsig E.Yu. i dr. Profilaktika i lechenie infektsiy verkhnikh dykhatel'nykh putey u detey. Lechashchiy vrach. 2001; 10. [in Russian]
73. Chow AW, Benninger MS, Brook I et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clin Infect Dis 2012; 54: e72–e112.
74. Fokkens WJ, Lund VJ, Mullol J et al. European Position Paper on Nasal Polyps 2012. Rhinology 2012; 50 (Suppl. 23): 1–298.
75. Anon JB. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management. Paediatr Drugs 2003; 5 (Suppl. 1): 25–33.
76. Payne SC, Benninger MS. Staphylococcus. Aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis. Clin Infect Dis 2007; 45 (10): e121–127.
77. Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children: a double-blind, placebo-controlled trial. Pediatrics 1986; 77: 795–800.
78. Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics 2009; 124: 9–15.
79. Garbutt JM, Goldstein M, Gellman E et al. A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics 2001; 107: 619–25.
80. Etiopatogeneticheskaya terapiya zabolevaniy verkhnikh dykhatel'nykh putey i ukha: metodicheskie rekomendatsii. Pod red. S.V.Ryazantseva. SPb.: Poliforum Grupp, 2015. [in Russian]
81. Cherkasova E.N., Kuznetsova T.A. Ostryy tonzillit na pediatricheskom uchastke: etiologicheskaya diagnostika i lechenie. Pediatricheskaya farmakologiya. 2015; 12 (2): 197–200. DOI: 10.15690/pf.v12i2.1283 [in Russian]
82. Katosova L.K., Namazova L.S., Kuznetsova M.N. i dr. Monitoring nositel'stva uslovno patogennoy mikroflory rotoglotki zdorovykh detey. Pediatricheskaya farmakologiya. 2007; 4 (2): 23–9. [in Russian]
83. Rusanova E.V., Feklisova L.V., Medvedeva E.A., Elezova L.I. Sostoianie mikrobioty slizistykh obolochek rotoglotki detei pri postuplenii v sanatorii. Sbornik annotirovannykh dokladov VI Vserossiiskoi nauchno-prakticheskoi konferentsii «Infektsionnye aspekty somaticheskoi patologii u detei», Moskva, 20–21 maia 2013; s. 93–5.  [in Russian]
84. Belov B.S., Grishaeva T.P. A-Streptokokkovyy tonzillit: sovremennye aspekty antibakterial'noy terapii. Pediatricheskaya farmakologiya. 2007; 4 (3): 58–66. [in Russian]
85. Cooper RJ, Hoffman JR, Bartlett JG et al, American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine; Centers for Disease Control. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001; 134: 509–17.
86. Little P, Gould C, Williamson I et al. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 1997; 315: 350–2.
87. Zwart S, Rovers MM, de Melker RA, Hoes AW. Penicillin for acute sore throat in children: randomised, double blind trial. BMJ 2003; 327: 1324.
88. Giraldez-Garcia C, Rubio B, Gallegos-Braun JF et al. Diagnosis and management of acute pharyngitis in a paediatric population: a cost-effectiveness analysis. Eur J Pediatr 2011; 170 (8): 1059–67.
89. Darmanyan A.S., Bakradze M.D. Problema ostrogo tonzillita v detskom vozraste. Med. sovet. Pediatriya. 2013; 3 (1): 69–72. [in Russian]
90. Domingues О, Rojo P, De las Heras S et al. Clinical presentation and characteristics of pharyngeal adenovirus infections. Pediatric Infect Dis J 2005; 24 (8): 733–44.
91. Cohen R, Levy C, Ovetchkine P et al. Evaluation of streptococcal clinical scores, rapid antigen detection tests and cultures for childhood pharyngitis. Eur J Pediatr 2004; 163: 281–2.
92. Lieu TA, Fleisher GR, Schwartz JS. Cost-effectiveness of rapid latex agglutination testing and throat culture for streptococcal pharyngitis. Pediatrics 1990; 85: 246–56.
93. Group ESTG, Pelucchi C, Grigoryan L et al. Guideline for the management of acute sore throat. Clin Microbiol Infect 2012; 18 (Suppl. 1): 1–28.
94. Chiappini E, Regoli M, Bonsignori F et al. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther 2011; 33: 48–58.
95. Katosova L.K., Ponomarenko O.A., Khokhlova T.A. i dr. Vozrastaiushchaia rezistentnost' k makrolidam Streptococcus pyogenes i molekuliarnye mekhanizmy ee opredeliaiushchie. Konferentsiia MAKMAKh. M., 2015. [in Russian]
96. Blasi F. Atypical pathogens and respiratory tract infections. Eur Respir J 2004; 24: 171–81.
97. Savenkova M.S. Khlamidiynaya i mikoplazmennaya infektsii v praktike pediatra. Consilium Medicum. Pediatrics (Suppl.). 2005; 1: 10–7. [in Russian]
98. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Sys Rev 2014: CD000245. DOI: 10.1002/14651858.CD000245.pub2
99. Ieven M. Diagnosis of Mycoplasma pneumoniae infections. Educational Workshop 07: Mycoplasma pneumoniae: epidemiology, diagnosis and treatment. 25th ECCMID, Copenhagen, Denmark, 25 April 2015 https: //www.escmid.org/ESGMI/
100. Spichak T.V., Katosova L.K., Iatsyshina S.B. i dr. Kriticheskii vzgliad na rezul'taty laboratornoi diagnostiki vnebol'nichnoi pnevmonii mikoplazmennoi etiologii u detei. Pediatriia. 2014; 87 (3): 46–55. [in Russian]
101. Nilsson AC, Björkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiology 2008; 8: 93. DOI: 10.1186/1471-2180-8-93
102. Spuesens EBM, Fraaij PLA, Visser EG et al. Carriage of Mycoplasma pneumoniae in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study. PLOS Med 2013; 10 (5): e1001444. DOI: 10.1371/journal.pmed.1001444
103. Kimpen JLL, Hammer J. Bronchiolitis in infants and children. Eur Respir Society Mon 2006; 37: 360.
104. Geppe N.A., Rozinova N.N., Volkov I.K., Mizernitskii Iu.L. Novaia rabochaia klassifikatsiia bronkholegochnykh zabolevanii u detei. Doktor.ru. Pediatriia. 2009; 1: 7–18. [in Russian]
105. Harris M., Clarc J., Coote N et al. British Thoracic Society guidelines for the management of Сommunity-acquired pneumonia in children: update 2011. Thorax 2011; 66 (6): 548–69.
106. Bradley JS, Byington CL, Shah SS et al. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53: e25–e76. http://cid.oxfordjournals.org/content/current
107. Tatochenko V.K. Pediatru na kazhdyi den' – 2012. Spravochnik po diagnostike i lecheniiu. Izd. 7-e, dop. M.: Borges, 2012; s. 72, 144–6. [in Russian]
108. Rudan I, Boschi-Pinto C, Biloglav Z et al. Epidemiology and etiology of childhood pneumonia. Bull WHO 2008; 86 (5): 408–16.
109. Hull J. Community-acquired pneumonia in children. Postgraduate Cours 15. Common respiratory infection in childhood: current guidelines and controversies. ERS Annual Cjngress Vienna 1–5 September 2012; p. 5–18.
110. Everard ML, Graven V, Fenton P. Community-acquired pneumonia. ERS handbook Paediatric Respiratory Medicie. 1st Ed. Eds. E.Eber, F.Medulla. Published by the European Respiratory Society, 2013; p. 233–41.
111. Esposito S, Patria MF, Tagliabue C et al. CAP in children. In: Community-acquired pneumonia. European respiratory monograph. V. 63. Eds: J.Chalmers, M.Pletz, S.Aliberti. 2014; p. 130–9.
112. Kim S.S., Spichak T.V., Iatsyshina S.B. i dr. Rol' virusov pri vnebol'nichnykh pnevmoniiakh u detei. Vopr. diagnostiki v pediatrii. 2012; 4 (4): 21–5. [in Russian]
113. Ieven M, Loens K. Should Serology be Abolished in Favor of PCR for the Diagnosis of Mycoplasma pneumoniae Infections? Cur Ped Rev 2013; 9: 4915–23.
114. Esposito S, Tagliabue C, Picciolli I et al. Procalcitonin measurement for guiding antibiotic treatment in pediatric pneumonia. Respir Med 2011; 105: 1939–45.
115. Baer G, Engelcke G, Abele-Horn M et al. Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents. Eur J Clin Microbiol Infect Dis 2003; 22 (12): 742–5.
116. Kim S.S. Effektivnye metody diagnostiki i lecheniia srednetiazhelykh vnebol'nichnykh pnevmonii u detei. Avtoref. dis. … kand. med. nauk. M., 2012. [in Russian]
117. Geppe N.A., Rozinova N.N., Volkov I.K. i dr. Vnebol'nichnaia pnevmoniia u detei. Klinicheskie rekomendatsii. M.: Original-maket, 2015. [in Russian]
118. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008; 16 (2): CD005976.
119. Vorob'ev P.A. Kachestvo meditsinskoi pomoshchi: problemy otsenki, kontrolia i upravleniia. Probl. standartizatsii v zdravookhranenii. 2007; 10: 6–14. [in Russian]
120. Vialkov A.I., Polesskii V.A., Martynchik S.A. Kliuchevye strategii VOZ po sovershenstvovaniiu natsional'nykh sistem zdravookhraneniia. Glavvrach. 2008; 5: 10–25. [in Russian]
121. D'iachenko V.G. Kachestvo v sovremennoi meditsine. Khabarovsk: DVGMU, 2007. [in Russian]
122. Eliseeva E.V., Gainullina Iu.I., Gel'tser B.I. Upravlenie kachestvom v sfere primeneniia antibakterial'nykh preparatov. Vladivostok: Dal'nauka, 2010. [in Russian]
123. Ivanova I.V., Starodubov V.I. Nekotorye pokazateli formirovaniia kadrovogo potentsiala meditsinskoi i farmatsevticheskoi nauki. Vestn. novykh med. tekhnologii. 2005; 12 (2): 105–7. [in Russian]
124. Mamedov D.A. Organizatsiia upravleniia informatsionnym resursom v munitsipal'nom uchrezhdenii zdravookhraneniia. Glavvrach. 2008; 5: 75–85. [in Russian]
125. Pirogov M.V. Razrabotka mediko-ekonomicheskikh standartov (opyt Moskovskoi oblasti). Glavvrach. 2009; 7: 41–54. [in Russian]
126. Pis'mo Minzdravsotsrazvitiia Rossiiskoi Federatsii №1242-VS ot 16.03.06. Spravochno-pravovaia sistema «Konsul'tantPlius». [in Russian]
127. Solodovnikov V.V., Gainullina Iu.I., Eliseeva E.V., Krivelevich V.Ia. Sovremennoe sostoianie problemy i znachenie sluzhby klinicheskoi farmakologii v optimizatsii ispol'zovaniia antibakterial'nykh lekarstvennykh sredstv. Probl. standartizatsii v zdravookhranenii. 2008; 9: 3–7. [in Russian]
128. How to investigate drug use in health facilities: selected drug use indicators. Geneva: World Health Organization, 2003.
129. Madaras-Kelly K. Optimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistance. Insights from the society of infectious diseases pharmacists. Pharmacotherapy 2003; 23 (12): 1627–33.

С.В.Яковлев4, В.В.Рафальский15,29, С.В.Сидоренко25,32, Т.В.Спичак4, Б.А.Абеуова1, А.М.Абидов2, С.Н.Авдеев3, И.А.Аполихина4,5, М.М.Асатова6, А.А.Аскеров7, Т.Ачылов, А.И.Баев8, М.Д.Бакрадзе9, Б.С.Белов10, Г.Г.Бояджян11, Н.Н.Бримкулов7, П.В.Буданов4, Н.А.Геппе4, В.Д.Гурбанова12,13, А.В.Гуров14, И.А.Гучев, Л.И.Дворецкий4, Е.В.Довгань15,16, И.А.Дронов4, М.В.Журавлева4, А.В.Зайцев17, А.Л.Заплатников18, И.Н.Захарова18, С.К.Зырянов14, Г.Н.Изотова19, В.А.Казанцев20, Н.Е.Кан5, О.В.Карнеева21, И.А.Карпов22, С.Л.Касенова23, А.А.Койбагарова7, А.И.Крюков14,19, И.В.Кузнецова4, И.В.Ливерко24, Ю.В.Лобзин25, А.М.Лукьянов22, А.Б.Малахов4, И.О.Малова26, Л.Ф.Можейко22, Э.Б.Мумладзе18, Г.Т.Мырзабекова27, Д.М.Ниткин28, Р.Э.Ниязметов6, Л.Г.Петрова28, Г.М.Пичхадзе23, Н.М.Подзолкова18, Т.В.Припутневич5, С.И.Роговская18, С.В.Рязанцев30, А.М.Савичева31, А.А.Самсонов17, В.М.Свистушкин4, Е.В.Соколовский33, Т.М.Сооронбаев34, М.П.Суворова4, Н.И.Тапильская35, В.К.Таточенко9, Н.И.Урсова36, А.А.Хрянин37, Н.И.Чернова17, Б.У.Шалекенов27, М.А.Шевяков32, Р.Г.Шмаков5

1 «Карагандинский государственный медицинский университет». 100008, Республика Казахстан, Караганда, ул. Гоголя, д. 40;
2 «Республиканский специализированный научно-практический медицинский центр дерматологии и венерологии» Минздрава Республики Узбекистан. 100109, Республика Узбекистан, Ташкент, ул. Фаробий, д. 3;
3 ФГБУ «НИИ пульмонологии» Минздрава России. 105077, Россия, Москва, ул. 11-я Парковая, д. 32;
4 ФГБОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2;
5 ФГБУ «Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова» Минздрава России. 117997, Россия, Москва, ул. Академика Опарина, д. 4;
6 «Ташкенский институт усовершенствования врачей» Минздрава Республики Узбекистан. 100007, Республика Узбекистан, Ташкент, ул. Паркентская, д. 51;
7 «Кыргызская государственная медицинская академия им. И.К.Ахунбаева». 720020, Кыргызская Республика, Бишкек, ул. Ахунбаева, д. 92;
8 «Научно-исследовательский кожно-венерологический институт» Минздравсоцразвития Республики Казахстан. 050002, Республика Казахстан, Алматы, пр-т Райымбека, д. 60;
9 ФГАУ «Научный центр здоровья детей» Минздрава России. 119991, Россия, Москва, Ломоносовский пр-т, д. 2, стр. 1;
10 ФГБНУ «НИИ ревматологии им. В.А.Насоновой». 115522, Россия, Москва, Каширское ш., д. 34а;
11 МК «Арабкир». 0014, Армения, Ереван, ул. Мамиконянц, д. 30;
12 Ассоциация «Содействие развитию гинекологии и перинатологии». AZ 1065, Азербайджанская Республика, Баку, ул. К.Казымзаде, д. 118;
13 Клиника International Medical Centre – Bakı. AZ 1142, Азербайджанская Республика, Баку, пр-т Бабека, д. 92 N;
14 ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1;
15 АНО «Институт клинической фармакологии». 214000, Россия, Смоленск, ул. Ново-Киевская, д. 9;
16 ОГБУЗ «Смоленская областная клиническая больница». 214018, Россия, Смоленск, пр. Гагарина, д. 27;
17 ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И.Евдокимова» Минздрава России. 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1;
18 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1;
19 ГБУЗ «Научно-исследовательский клинический институт оториноларингологии им. Л.И.Свержевского» Департамента здравоохранения г. Москвы. 117152, Россия, Москва, Загородное ш., д. 18а, стр. 2;
20 ФГБВОУ ВО «Военно-медицинская академия им. С.М.Кирова» Минобороны России. 194044, Россия, Санкт-Петербург, ул. Академика Лебедева, д. 6;
21 ФГБУ «Научно-клинический центр оториноларингологии ФМБА России». 123182, Россия, Москва, Волоколамское ш., д. 30, корп. 2;
22 УО «Белорусский государственный медицинский университет». 220116, Республика Беларусь, Минск, пр-т Дзержинского, д. 83;
23 «Казахский национальный медицинский университет им. С.Д.Асфендиярова». 050012, Республика Казахстан, Алматы, ул. Толе Би, д. 88;
24 «Республиканский специализированный научно-практический медицинский центр фтизиатрии и пульмонологии». 100086, Республика Узбекистан, Ташкент, ул. Алимова, д. 1;
25 ФГБУ «НИИ детских инфекций» ФМБА России. 197022, Россия, Санкт-Петербург, ул. Профессора Попова, д. 9;
26 ФГБОУ ВО «Иркутский государственный медицинский университет» Минздрава России. 664003, Россия, Иркутск, ул. Красного Восстания, д. 1;
27 АО «Казахский медицинский университет непрерывного образования». 050057, Республика Казахстан, Алматы, ул. Манаса, д. 34;
28 ГУО «Белорусская медицинская академия последипломного образования». 220013, Республика Беларусь, Минск, ул. П.Бровки, д. 3, корп. 3;
29 ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России. 214019, Россия, Смоленск, ул. Крупской, д. 28;
30 ФГБУ «Санкт-Петербургский НИИ уха, горла, носа и речи» Минздрава России. 190013, Россия, Санкт-Петербург, ул. Бронницкая, д. 9;
31 ФГБНУ «НИИ акушерства, гинекологии и репрудоктологии им. Д.И.Отта». 199034, Россия, Санкт-Петербург, Менделеевская линия, д. 3;
32 ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И.Мечникова» Минздрава России. 191015, Россия, Санкт-Петербург, ул. Кирочная, д. 41;
33 ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова» Минздрава России. 197022, Россия, Санкт-Петербург, ул. Льва Толстого, д. 6/8;
34 «Национальный центр кардиологии и терапии им. акад. Мирсаида Миррахимова» Минздрава Кыргызской Республики. 720040, Кыргызская Республика, Бишкек, ул. Тоголок Молдо, д. 3;
35 ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России. 194100, Россия, Санкт-Петербург, Литовская ул., д. 2;
36 ГБУЗ «Московский областной научно-исследовательский клинический институт им. М.Ф.Владимирского». 129110, Россия, Москва, ул. Щепкина, д. 61/2;
37 ФГБОУ ВО «Новосибирский государственный медицинский университет» Минздрава России. 630091, Россия, Новосибирск, ул. Красный пр-т, д. 52

________________________________________________

S.V.Yakovlev4, V.V.Rafalskiy15,29, S.V.Sidorenko25,32, T.V.Spichak4, B.A.Abeuova1, A.M.Abidov2, S.N.Avdeev3, I.A.Apolikhina4,5, M.M.Asatova6, A.A.Askerov7, T.Achylov, A.I.Baev8, M.D.Bakradze9, B.S.Belov10, G.G.Boyadzhyan11, N.N.Brimkulov7, P.V.Budanov4, N.A.Geppe4, V.D.Gurbanova12,13, A.V.Gurov14, I.A.Guchev, L.I.Dvoretskiy4, E.V.Dovgan15,16, I.A.Dronov4, M.V.Zhuravleva4, A.V.Zaytsev17, A.L.Zaplatnikov18, I.N.Zakharova18, S.K.Zyryanov14, G.N.Izotova19, V.A.Kazantsev20, N.E.Kan5, O.V.Karneeva21, I.A.Karpov22, S.L.Kasenova23, A.A.Koybagarova7, A.I.Kryukov14,19, I.V.Kuznetsova4, I.V.Liverko24, Yu.V.Lobzin25, A.M.Lukyanov22, A.B.Malakhov4, I.O.Malova26, L.F.Mozheyko22, E.B.Mumladze18, G.T.Myrzabekova27, D.M.Nitkin28, R.E.Niyazmetov6, L.G.Petrova28, G.M.Pichkhadze23, N.M.Podzolkova18, T.V.Priputnevich5, S.I.Rogovskaya18, S.V.Ryazantsev30, A.M.Savicheva31, A.A.Samsonov17, V.M.Svistushkin4, E.V.Sokolovskiy33, T.M.Sooronbaev34, M.P.Suvorova4, N.I.Tapilskaya35, V.K.Tatochenko9, N.I.Ursova36, A.A.Khryanin37, N.I.Chernova17, B.U.Shalekenov27, M.A.Shevyakov32, R.G.Shmakov5

1 Karaganda State Medical University. 100008, Republic of Kazakhstan, Karaganda, ul. Gogolia, d. 40;
2 Republican Specialized Scientific and Practical Medical Center of Dermatology and Venereology of the Ministry of Health of the Republic of Uzbekistan. 100109, Republic of Uzbekistan, Tashkent, ul. Farobiy, d. 3;
3 Scientific-Research Institute of Pulmonology. 105077, Russian Federation, Moscow, ul. 11-ia Parkovaia, d. 32;
4 I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2;
5 V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4;
6 Tashkent Institute of Postgraduate Medical Education of the Ministry of Health of the Republic of Uzbekistan. 100007, Republic of Uzbekistan, Tashkent, ul. Parkentskaya, d. 51;
7 I.K.Akhunbaev Kyrgyz State Medical Academy. 720020, Kyrgyzstan, Bishkek, ul. Akhunbaeva, d. 92;
8 Research Institute for Skin and Venereal Diseases of the Ministry of Healthcare and Social Development of the Republic of Kazakhstan. 050002, Republic of Kazakhstan, Almaty, pr-t Raiymbeka, d. 60;
9 Scientific Center of Children Health of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, Lomonosovskii pr-t, d. 2, str. 1;
10 V.A.Nasonova Research Institute of Rheumatology. 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a;
11 Arabkir. 0014, Republic of Armenia, Erevan, ul. Mamikoniants, d. 30;
12 “Support to Development of Gynaecology and Perinotology” Association. AZ 1065, Azerbaijan, Baku, ul. K.Kazimzadeh, d. 118;
13 Сlinic “International Medical Centre – Bakı”. AZ 1142, Azerbaijan, Baku, pr-t Babeka, d. 92 N;
14 N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1;
15 Institute of Clinical Pharmacology. 214000, Russian Federation, Smolensk, ul. Novo-Kievskaya, d. 9;
16 Smolensk Regional Clinical Hospital. 214018, Russian Federation, Smolensk, pr. Gagarina, d. 27
17 A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation. 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1;
18 Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1;
19 L.I.Sverzhevskiy Research Institute of Clinical Otorhinolaryngology of the Department of Health of Moscow. 117152, Russian Federation, Moscow, Zagorodnoe sh., d. 18a;
20 S.M.Kirov Military-Medical Academy of the Ministry of Defense of the Russian Federation. 194044, Russian Federation, Saint Petersburg, ul. Akademika Lebedeva, d. 6;
21 Research and Clinical Center of Otorhinolaryngology. 123182, Russian Federation, Moscow, Volokolamskoe sh., d. 30, korp. 2;
22 Belarusian State Medical University. 220116, Republic of Belarus, Minsk, pr-t Dzerzhinskogo, d. 83;
23 S.D.Asfendiyarov Kazakh National Medical University. 050012, Republic of Kazakhstan, Almaty, ul. Tole Bi, d. 88;
24 Republican Specialized Scientific-Practical Medical Center of Tuberculosis and Pulmonology. 100086, Republic of Uzbekistan, Tashkent, ul. Alimova, d. 1;
25 Research Institute of Children's Infections. 197022, Russian Federation, Saint Petersburg, ul. Professora Popova, d. 9;
26 Irkutsk State Medical University of the Ministry of Health of the Russian Federation. 664003, Russian Federation, Irkutsk, ul. Krasnogo Vosstaniia, d. 1;
27 Kazakh Medical University of Continuing Education. 050057, Republic of Kazakhstan, Almaty, ul. Manasa, d. 34;
28 Belarusian Medical Academy of Postgraduate Education. 220013, Republic of Belarus, Minsk, ul. P.Brovki, d. 3, korp. 3;
29 Smolensk State Medical University of the Ministry of Health of the Russian Federation. 214019, Russian Federation, Smolensk, ul. Krupskoi, d. 28;
30 Saint Petersburg Institute of Ear, Nose, Throat and Speech of the Ministry of Health of the Russian Federation. 190013, Russian Federation, Saint Petersburg, ul. Bronnitskaia, d. 9;
31 D.O.Ott Research Institute of Obstetrics Gynecology and Reproductology. 199034, Russian Federation, Saint Petersburg, Mendeleyevskaya line, d. 3;
32 I.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian Federation. 191015, Russian Federation, Saint Petersburg, ul. Kirochnaia, d. 41;
33 I.P.Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation. 197022, Russian Federation, Saint Petersburg, ul. L'va Tolstogo, d. 6/8;
34 Mirsaid Mirrahimov National Center of Cardiology and Therapy of the Ministry of Health of the Kyrgyz Republic. 720040, Kyrgyz Republic, Bishkek, ul. Togolok Moldo, d. 3;
35 Saint Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation. 194100, Russian Federation, Saint Petersburg, Litovskaja ul., d. 2;
36 M.F.Vladimirskiy Moscow Regional Research Clinical Institute. 129110, Russian Federation, Moscow, ul. Shchepkina, d. 61/2;
37 Novosibirsk State Medical University of the Ministry of Health of the Russian Federation. 630091, Russian Federation, Novosibirsk, ul. Krasnyi pr-t, d. 52